On October 30, 2024, Chemical & Biomedical Imaging（CBMI） was officially indexed in the PubMed Central database.
This milestone means that all articles published by CBMI since its inception will be accessible to global readers via the PubMed website. The indexing by PMC not only signifies international recognition of CBMI's publishing quality and standards but also plays a crucial role in enhancing its global impact.
CBMI extends its heartfelt gratitude to all experts, scholars, authors, readers, reviewers, and the editorial team for their invaluable support and contributions. The journal remains dedicated to its mission of providing a high-quality platform for scholars in the fields of chemical and biomedical imaging.
Since its inaugural issue in April 2023, CBMI has successfully published 19 issues featuring a total of 158 high-quality articles, which have collectively garnered over 220,000 reads and are steadily increasing in impact. Looking ahead, CBMI will continue to collaborate with researchers to explore the vast possibilities in chemical and biomedical imaging, advance disciplinary development, promote knowledge dissemination, and contribute to the establishment of a thriving academic ecosystem.
Call for Papers:
https://mp.weixin.qq.com/s/x3JnI2kscVsDdIsHW04WhA
https://mp.weixin.qq.com/s/-rssP_F1MEhKLo_DaqubbA
https://mp.weixin.qq.com/s/VN1cu6QnhdbpmXM_l4-2ow
Article Interpretations：
https://mp.weixin.qq.com/s/MmqNVLNqR8G-EzpW30b4Mw
https://mp.weixin.qq.com/s/OCw0AgjJaYamwofsxViHrg
https://mp.weixin.qq.com/s/vjYFc-67CiPO8zw5dWskgw
https://mp.weixin.qq.com/s/72KOIoan5BVPmfmGamudpw
https://mp.weixin.qq.com/s/V7e9UMG23ubXEp5xVI3-vA
https://mp.weixin.qq.com/s/unzfj5xQN57VBJfwo0DfpQ
https://mp.weixin.qq.com/s/pGYjALpwy9shQ4zrQEcMjw
Journal Development:
https://mp.weixin.qq.com/s/ldKcyXpFZPLddQ0RLbaorw
https://mp.weixin.qq.com/s/4i7nO8y7MOoW5BeSDjDP1g
https://mp.weixin.qq.com/s/CYGio9b3SI8wXX6fJ9G2tg